Daphne W Bell
9PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 15, 2025
Proteomic Changes Associated With Endogenous FBXW7 Mutations in Moderately Differentiated Endometrial Cancer Cells Include Increased TROP2 and Galectin-3 Levels.Mary Ellen Urick, Suresh Kumar Chalapareddy, Eun-Jeong Yu
|Nov 22, 2024
The endometrial cancer A230V-ALK5 (TGFBR1) mutant attenuates TGF-β signaling and exhibits reduced in vitro sensitivity to ALK5 inhibitors.Eun-Jeong Yu, Daphne W Bell
|Jan 26, 2022
KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas.Meghan L Rudd, Nancy F Hansen, Xiaolu Zhang
|Jul 29, 2021
Reply to FBXW7, L1CAM, and TGM2 in endometrial cancer.Mary Ellen Urick, Eun-Jeong Yu, Daphne W Bell
|Apr 19, 2021
High-risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels.Mary Ellen Urick, Eun-Jeong Yu, Daphne W Bell
|Apr 06, 2020
Proteomic profiling of FBXW7-mutant serous endometrial cancer cells reveals upregulation of PADI2, a potential therapeutic target.Mary Ellen Urick, Daphne W Bell
Pageof 2
